September 17, 2026 CGIC 2026 is in the Books: The Path Forward Wednesday at #CGIC2026 closed out the conference with a focus on data sharing, patient voices, and emerging technologies.
September 16, 2026 C-Path’s #CGIC2026 Day 1 in the Books + What’s ahead on Wednesday Day 1 at #CGIC2026 set the tone for the conference.
September 15, 2026-September 16, 2026 Register Now: C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
September 15, 2026 C-Path’s Translational Therapeutics Accelerator Awards $1.7 Million Across Five BRIDGe Grants in Brain Health, Pediatrics and Rare Disease Five research teams advance small molecule, protein-based and gene therapy candidates for conditions where existing options fall s
September 3, 2026 C-Path Mourns the Passing of Board Member Peter Barton Hutt TUCSON, Ariz., September 3, 2026 — Critical Path Institute® (C-Path) is deeply saddened to announce the passing of Peter...
September 3, 2026 Advancing Neuromuscular Drug Development Through Patient-Centered Collaboration and Data Integration The newest episode of the Critical Path Institute Podcast explores the essential collaboration between patients...
August 27, 2026 From One to Millions: Julia Vitarello on a New Vision for Individualized Medicine "I'm very, very determined to play a role together with everyone at C-Path and others to try to make sure that the millions of...
August 25, 2026 Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...
August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...
August 24, 2026 Successful Translational Prediction of Bedaquiline’s Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology Tuberculosis remains an urgent global health crisis that requires an accelerated development of novel regimens.